-
1
-
-
0033577556
-
Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis
-
The LIOn Study Group
-
Evans EG, Sigurgeirsson B. Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LIOn Study Group. BMJ 1999; 318: 1031-5.
-
(1999)
BMJ
, vol.318
, pp. 1031-1035
-
-
Evans, E.G.1
Sigurgeirsson, B.2
-
2
-
-
0032759953
-
LIOn Study. Efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Lamisil vs. itraconazole in onychomycosis
-
Sigurgeirsson B, Billstein S, Rantanen T, Ruzicka T, di Fonzo E, Vermeer BJ et al. LIOn Study. Efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Lamisil vs. itraconazole in onychomycosis. Br J Dermatol 1999; 141 (Suppl. 56): 5-14.
-
(1999)
Br J Dermatol
, vol.141
, Issue.56 SUPPL.
, pp. 5-14
-
-
Sigurgeirsson, B.1
Billstein, S.2
Rantanen, T.3
Ruzicka, T.4
Di Fonzo, E.5
Vermeer, B.J.6
-
3
-
-
0036120887
-
Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: A 5-year blinded prospective follow-up study
-
Sigurgeirsson B, Olafsson JH, Steinsson JB, Paul C, Billstein S, Evans EG. Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study. Arch Dermatol 2002; 138: 353-7.
-
(2002)
Arch Dermatol
, vol.138
, pp. 353-357
-
-
Sigurgeirsson, B.1
Olafsson, J.H.2
Steinsson, J.B.3
Paul, C.4
Billstein, S.5
Evans, E.G.6
-
4
-
-
0026210756
-
Onychomycosis treated with itraconazole or griseofulvin alone with and without a topical antimycotic or keratolytic agent
-
Arenas R, Fernandez G, Dominguez L. Onychomycosis treated with itraconazole or griseofulvin alone with and without a topical antimycotic or keratolytic agent. Int J Dermatol 1991; 30: 586-9.
-
(1991)
Int J Dermatol
, vol.30
, pp. 586-589
-
-
Arenas, R.1
Fernandez, G.2
Dominguez, L.3
-
5
-
-
0023267383
-
A comparison of tioconazole 28% nail solution versus base as an adjunct to oral griseofulvin in patients with onychomycosis
-
Hay RJ, Clayton YM, Moore MK. A comparison of tioconazole 28% nail solution versus base as an adjunct to oral griseofulvin in patients with onychomycosis. Clin Exp Dermatol 1987; 12: 175-7.
-
(1987)
Clin Exp Dermatol
, vol.12
, pp. 175-177
-
-
Hay, R.J.1
Clayton, Y.M.2
Moore, M.K.3
-
6
-
-
0001838681
-
Combination of amorolfine with griseofulvin: In vitro activity and clinical results in onychomycosis
-
Lauharanta J, Zaug M, Polak A, Reinel D. Combination of amorolfine with griseofulvin: In vitro activity and clinical results in onychomycosis. JAMA SEA 1993.
-
(1993)
JAMA SEA
-
-
Lauharanta, J.1
Zaug, M.2
Polak, A.3
Reinel, D.4
-
7
-
-
0034764051
-
Topical amorolfine for 15 months combined with 12 weeks of oral terbinafine, a cost-effective treatment for onychomycosis
-
Baran R. Topical amorolfine for 15 months combined with 12 weeks of oral terbinafine, a cost-effective treatment for onychomycosis. Br J Dermatol 2001; 145 (Suppl. 60): 15-9.
-
(2001)
Br J Dermatol
, vol.145
, Issue.60 SUPPL.
, pp. 15-19
-
-
Baran, R.1
-
8
-
-
0034765185
-
Amorolfine and itraconazole combination for severe toenail onychomycosis: Results of an open randomized trial in spain
-
Lecha M. Amorolfine and itraconazole combination for severe toenail onychomycosis: results of an open randomized trial in spain. Br J Dermatol 2001; 145 (Suppl. 60): 21-6.
-
(2001)
Br J Dermatol
, vol.145
, Issue.60 SUPPL.
, pp. 21-26
-
-
Lecha, M.1
|